NEW YORK (GenomeWeb) – PerkinElmer announced Tuesday it has signed an agreement to serve as the exclusive collaborator with China's National Health and Family Planning Commission to create and implement a newborn screening training program focused on rural China.

Under the three-year agreement, PerkinElmer will provide its diagnostic tests and expertise to develop and roll out a program that will "substantially increase adoption and access to newborn screening in China," the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.